Let's go What is this?

A medical diagnosis company headquartered in California, USA, provides diagnosis solutions and is committed to improving people's health and happiness, improving the treatment effect of patients and optimizing the economic benefits of the medical and health system. Aauto Quicker was founded in 1979 (Nasdaq: QDEL), and the first product was launched in 1983. Since then, Aauto Quicker has accelerated product innovation and greatly enriched its product line through internal R&D and mergers and acquisitions.

20 18, Kuaizhen officially entered the China market. The main business includes:

Myocardial marker detector and its matching reagent

In 20 17, Quidel reached a global agreement with Abbott to acquire some of its product lines, including triage myocardial markers and toxicology tests, formerly known as Biosite Bosch.

Quidel Kuaizhen China Company was established on 20 18, taking over the triage business and sales channels in an all-round way, and providing products and services to customers in China.

After the acquisition, Quidel paid attention to the sustainable development of cardiac marker business, and the newly developed POCT hypersensitive troponin went on the market in Europe in 20 19, which was widely recognized by experts.

Respiratory tract antigen detector and its matching reagent

20 17, D3 Ultra Seven respiratory antigen test kit was introduced to China.

In 20 19, Sophia dry fluorescence immunoassay system and influenza A/B antigen detection reagent were listed in China.

In 2020, Sofia RSV respiratory antigen detection reagent was listed in China.

202 1, Sofia 2 dry fluorescence immunoassay system is listed in China. Sofia Q rapid antigen detection obtained by fluorescence immunoassay